Target
Mitogen-activated protein kinase 14
Ligand
BDBM50347110
Substrate
n/a
Meas. Tech.
ChEMBL_752994 (CHEMBL1798818)
IC50
8±n/a nM
Citation
 Selness, SRBoehm, TLWalker, JKDevadas, BDurley, RCKurumbail, RShieh, HXing, LHepperle, MRucker, PVJerome, KDBenson, AGMarrufo, LDMadsen, HMHitchcock, JOwen, TJChristie, LPromo, MAHickory, BSAlvira, ENaing, WBlevis-Bal, RDevraj, RVMessing, DSchindler, JFHirsch, JSaabye, MBonar, SWebb, EAnderson, GMonahan, JB Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase. Bioorg Med Chem Lett 21:4059-65 (2011) [PubMed]  Article 
Target
Name:
Mitogen-activated protein kinase 14
Synonyms:
CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta
Type:
Serine/threonine-protein kinase
Mol. Mass.:
41286.76
Organism:
Homo sapiens (Human)
Description:
Q16539
Residue:
360
Sequence:
MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
  
Inhibitor
Name:
BDBM50347110
Synonyms:
CHEMBL1797213
Type:
Small organic molecule
Emp. Form.:
C21H17ClF4N2O2
Mol. Mass.:
440.818
SMILES:
CN(C)Cc1cc(OCc2ccc(F)cc2F)c(Cl)c(=O)n1-c1c(F)cccc1F |(29.59,-20.31,;28.25,-21.07,;26.92,-20.3,;28.25,-22.61,;26.91,-23.38,;25.58,-22.6,;24.25,-23.38,;22.92,-22.61,;21.58,-23.39,;20.25,-22.62,;18.93,-23.4,;17.59,-22.64,;17.58,-21.09,;16.25,-20.33,;18.92,-20.32,;20.25,-21.08,;21.58,-20.31,;24.25,-24.92,;22.92,-25.69,;25.58,-25.68,;25.58,-27.22,;26.91,-24.92,;28.24,-25.69,;29.57,-24.92,;29.56,-23.38,;30.9,-25.69,;30.9,-27.24,;29.56,-28,;28.23,-27.23,;26.9,-28,)|
Structure:
Search PDB for entries with ligand similarity: